NEW YORK, April 4 (GenomeWeb News) - Shares of Transgenomic were down 5.63 percent, or $.04, at $.67 in mid-afternoon trading after the company said CEO Collin D'Silva has resigned.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.
NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.
A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.
In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.